Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.
Identifieur interne : 000742 ( PubMed/Corpus ); précédent : 000741; suivant : 000743Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.
Auteurs : F Y Alqahtani ; F S Aleanizy ; R. Ali El Hadi Mohamed ; M S Alanazi ; N. Mohamed ; M M Alrasheed ; N. Abanmy ; T. AlhawassiSource :
- Epidemiology and infection [ 1469-4409 ] ; 2018.
Abstract
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a life-threatening respiratory disease with a high case fatality rate; however, its risk factors remain unclear. We aimed to explore the influence of demographic factors, clinical manifestations and underlying comorbidities on mortality in MERS-CoV patients. Retrospective chart reviews were performed to identify all laboratory-confirmed cases of MERS-COV infection in Saudi Arabia that were reported to the Ministry of Health of Saudi Arabia between 23 April 2014 and 7 June 2016. Statistical analyses were conducted to assess the effect of sex, age, clinical presentation and comorbidities on mortality from MERS-CoV. A total of 281 confirmed MERS-CoV cases were identified: 167 (59.4%) patients were male and 55 (20%) died. Mortality predominantly occurred among Saudi nationals and older patients and was significantly associated with respiratory failure and shortness of breath. Of the 281 confirmed cases, 160 (56.9%) involved comorbidities, wherein diabetes mellitus, hypertension, ischemic heart disease, congestive heart failure, end-stage renal disease and chronic kidney disease were significantly associated with mortality from MERS-CoV and two or three comorbidities significantly affected the fatality rates from MERS-CoV. The findings of this study show that old age and the existence of underlying comorbidities significantly increase mortality from MERS-CoV.
DOI: 10.1017/S0950268818002923
PubMed: 30394248
Links to Exploration step
pubmed:30394248Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.</title>
<author><name sortKey="Alqahtani, F Y" sort="Alqahtani, F Y" uniqKey="Alqahtani F" first="F Y" last="Alqahtani">F Y Alqahtani</name>
<affiliation><nlm:affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aleanizy, F S" sort="Aleanizy, F S" uniqKey="Aleanizy F" first="F S" last="Aleanizy">F S Aleanizy</name>
<affiliation><nlm:affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ali El Hadi Mohamed, R" sort="Ali El Hadi Mohamed, R" uniqKey="Ali El Hadi Mohamed R" first="R" last="Ali El Hadi Mohamed">R. Ali El Hadi Mohamed</name>
<affiliation><nlm:affiliation>College of Science, Princess Nourah Bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alanazi, M S" sort="Alanazi, M S" uniqKey="Alanazi M" first="M S" last="Alanazi">M S Alanazi</name>
<affiliation><nlm:affiliation>Emergency medicine consultant,Emergency Department,Prince Mohamed Bin Abdulaziz Hospital,Ministry of Health,Riyadh 12455,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mohamed, N" sort="Mohamed, N" uniqKey="Mohamed N" first="N" last="Mohamed">N. Mohamed</name>
<affiliation><nlm:affiliation>College of Medicine, Princess Nourah bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alrasheed, M M" sort="Alrasheed, M M" uniqKey="Alrasheed M" first="M M" last="Alrasheed">M M Alrasheed</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Abanmy, N" sort="Abanmy, N" uniqKey="Abanmy N" first="N" last="Abanmy">N. Abanmy</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhawassi, T" sort="Alhawassi, T" uniqKey="Alhawassi T" first="T" last="Alhawassi">T. Alhawassi</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30394248</idno>
<idno type="pmid">30394248</idno>
<idno type="doi">10.1017/S0950268818002923</idno>
<idno type="wicri:Area/PubMed/Corpus">000742</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000742</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.</title>
<author><name sortKey="Alqahtani, F Y" sort="Alqahtani, F Y" uniqKey="Alqahtani F" first="F Y" last="Alqahtani">F Y Alqahtani</name>
<affiliation><nlm:affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aleanizy, F S" sort="Aleanizy, F S" uniqKey="Aleanizy F" first="F S" last="Aleanizy">F S Aleanizy</name>
<affiliation><nlm:affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ali El Hadi Mohamed, R" sort="Ali El Hadi Mohamed, R" uniqKey="Ali El Hadi Mohamed R" first="R" last="Ali El Hadi Mohamed">R. Ali El Hadi Mohamed</name>
<affiliation><nlm:affiliation>College of Science, Princess Nourah Bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alanazi, M S" sort="Alanazi, M S" uniqKey="Alanazi M" first="M S" last="Alanazi">M S Alanazi</name>
<affiliation><nlm:affiliation>Emergency medicine consultant,Emergency Department,Prince Mohamed Bin Abdulaziz Hospital,Ministry of Health,Riyadh 12455,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mohamed, N" sort="Mohamed, N" uniqKey="Mohamed N" first="N" last="Mohamed">N. Mohamed</name>
<affiliation><nlm:affiliation>College of Medicine, Princess Nourah bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alrasheed, M M" sort="Alrasheed, M M" uniqKey="Alrasheed M" first="M M" last="Alrasheed">M M Alrasheed</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Abanmy, N" sort="Abanmy, N" uniqKey="Abanmy N" first="N" last="Abanmy">N. Abanmy</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhawassi, T" sort="Alhawassi, T" uniqKey="Alhawassi T" first="T" last="Alhawassi">T. Alhawassi</name>
<affiliation><nlm:affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Epidemiology and infection</title>
<idno type="eISSN">1469-4409</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Middle East respiratory syndrome coronavirus (MERS-CoV) is a life-threatening respiratory disease with a high case fatality rate; however, its risk factors remain unclear. We aimed to explore the influence of demographic factors, clinical manifestations and underlying comorbidities on mortality in MERS-CoV patients. Retrospective chart reviews were performed to identify all laboratory-confirmed cases of MERS-COV infection in Saudi Arabia that were reported to the Ministry of Health of Saudi Arabia between 23 April 2014 and 7 June 2016. Statistical analyses were conducted to assess the effect of sex, age, clinical presentation and comorbidities on mortality from MERS-CoV. A total of 281 confirmed MERS-CoV cases were identified: 167 (59.4%) patients were male and 55 (20%) died. Mortality predominantly occurred among Saudi nationals and older patients and was significantly associated with respiratory failure and shortness of breath. Of the 281 confirmed cases, 160 (56.9%) involved comorbidities, wherein diabetes mellitus, hypertension, ischemic heart disease, congestive heart failure, end-stage renal disease and chronic kidney disease were significantly associated with mortality from MERS-CoV and two or three comorbidities significantly affected the fatality rates from MERS-CoV. The findings of this study show that old age and the existence of underlying comorbidities significantly increase mortality from MERS-CoV.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">30394248</PMID>
<DateRevised><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2018</Year>
<Month>Nov</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Epidemiology and infection</Title>
<ISOAbbreviation>Epidemiol. Infect.</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study.</ArticleTitle>
<Pagination><MedlinePgn>1-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268818002923</ELocationID>
<Abstract><AbstractText>The Middle East respiratory syndrome coronavirus (MERS-CoV) is a life-threatening respiratory disease with a high case fatality rate; however, its risk factors remain unclear. We aimed to explore the influence of demographic factors, clinical manifestations and underlying comorbidities on mortality in MERS-CoV patients. Retrospective chart reviews were performed to identify all laboratory-confirmed cases of MERS-COV infection in Saudi Arabia that were reported to the Ministry of Health of Saudi Arabia between 23 April 2014 and 7 June 2016. Statistical analyses were conducted to assess the effect of sex, age, clinical presentation and comorbidities on mortality from MERS-CoV. A total of 281 confirmed MERS-CoV cases were identified: 167 (59.4%) patients were male and 55 (20%) died. Mortality predominantly occurred among Saudi nationals and older patients and was significantly associated with respiratory failure and shortness of breath. Of the 281 confirmed cases, 160 (56.9%) involved comorbidities, wherein diabetes mellitus, hypertension, ischemic heart disease, congestive heart failure, end-stage renal disease and chronic kidney disease were significantly associated with mortality from MERS-CoV and two or three comorbidities significantly affected the fatality rates from MERS-CoV. The findings of this study show that old age and the existence of underlying comorbidities significantly increase mortality from MERS-CoV.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alqahtani</LastName>
<ForeName>F Y</ForeName>
<Initials>FY</Initials>
<AffiliationInfo><Affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aleanizy</LastName>
<ForeName>F S</ForeName>
<Initials>FS</Initials>
<AffiliationInfo><Affiliation>Department of Pharmaceutics,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ali El Hadi Mohamed</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>College of Science, Princess Nourah Bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alanazi</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo><Affiliation>Emergency medicine consultant,Emergency Department,Prince Mohamed Bin Abdulaziz Hospital,Ministry of Health,Riyadh 12455,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mohamed</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>College of Medicine, Princess Nourah bint Abdulrahman University,Riyadh 12484,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alrasheed</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Abanmy</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alhawassi</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Pharmacy,College of Pharmacy, King Saud University,22452 Riyadh 11495,Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Epidemiol Infect</MedlineTA>
<NlmUniqueID>8703737</NlmUniqueID>
<ISSNLinking>0950-2688</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Comorbidities</Keyword>
<Keyword MajorTopicYN="N">middle east respiratory syndrome coronavirus</Keyword>
<Keyword MajorTopicYN="N">mortality</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30394248</ArticleId>
<ArticleId IdType="pii">S0950268818002923</ArticleId>
<ArticleId IdType="doi">10.1017/S0950268818002923</ArticleId>
<ArticleId IdType="pmc">PMC6518603</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Mol Syst Biol. 2009;5:262</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19357641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2013 May;7(3):410-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22817648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012 Oct 04;17(40):20290</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23078800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2012 Nov 20;3(6):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jul;87(14):7790-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23678167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jun 27;368(26):2487-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23718156</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1361-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23721100</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2013 Jun 13;18(24):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23787162</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2013 Sep;17(9):e668-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23916548</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2013 Aug 23;347:f5061</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23974637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2013 Dec 14;382(9909):1993-2002</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24055451</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2014 Jan;14(1):50-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24239323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2014 Mar 18;160(6):389-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24474051</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2014 Jun;23:63-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24699184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Jul 15;59(2):160-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24723278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Bioinformatics. 2014 Oct 24;15:333</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25344230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Curr. 2014 Dec 18;6:null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25685622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2015 Feb 26;372(9):846-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25714162</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Teach. 2015 Apr;37 Suppl 1:S88-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25803593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Rev. 2015 Apr;28(2):465-522</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25810418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26049252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2016 Sep 15;184(6):460-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27608662</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2017 Jan 5;17(1):23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28056850</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2017 Jun 7;6(6):e51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28588290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2017 Oct 13;12(10):e0183850</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29028812</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000742 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000742 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:30394248 |texte= Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:30394248" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |